Skip to main content
. 2023 Feb 9;5(2):fcad027. doi: 10.1093/braincomms/fcad027

Table 1.

Demographic and clinical characteristics and prevalence of reward behavioural changes for all participant groups

Characteristic Controls AD lvPPA bvFTD svPPA nfvPPA
General
No. (m:f) 42 (23:19) 34 (18:16) 12 (10:2) 27 (20:7) 22 (13:9) 24 (14:10)
Handed (R:L) 40:2 30:4 11:1 26:1 21:1 23:1
Age (y) 66.8 (6.5) 70.7 (8.1) 67.6 (9.1) 66.7 (7.7) 66.3 (7.1) 70.9 (8.1)
Education (y) 16.0 (12.2–17.0) 16.0 (12.2–16.0) 15.0 (13.8–16.2) 14.0 (12.0–16.0) 16.0 (11.2–16.0) 13.5 (11.0–16.0)
Illness (y) NA 5.3 (4.2–7.6) 5.3 (4.3–6.8) 4.9 (4.0–6.0) 5.3 (4.6–6.3) 4.3 (2.6–5.1)
MMSE score 30.0 (29.0–30.0) 18.5 (16.2–25.0) 12.5 (10.0–17.0)a,b 24.0 (21.0–27.5)c 23.5 (18.0–28.5)c 25.5 (17.2–8.0)
Reward domains
No. (%)
 Primary
  Any 4 (10) 20 (59) 4 (33) 24 (89)d,c,e 18 (82)c 12 (50)a
  Inc 2 (5) 13 (38)a 3 (25) 23 (85)d,c,e 15 (68) 10 (42)a
  Dec 2 (5) 9 (26) 2 (17) 13 (48) 8 (36) 4 (17)
 Appetite
  Any 2 (5) 14 (41) 1 (8) 19 (70)c 14 (64)c 11 (46)
  Inc 0 (0) 5 (15)a 0 (0)a 15 (56)c,d 8 (36) 7 (29)
  Dec 2 (5) 9 (26) 1 (8) 4 (15) 6 (27) 4 (17)
 Sweet tooth
  Any (Inc) 2 (5) 12 (35)a 3 (25)a 20 (74)c–e 13 (59) 7 (29)a
 Sex
  Any 0 (0) 2 (6)a 2 (17) 14 (52)d,e 6 (27) 3 (12)a
  Inc 0 (0) 0 (0) 0 (0) 3 (11) 3 (14) 2 (8)
  Dec 0 (0) 2 (6)a 2 (17) 11 (41)d,e 3 (14) 1 (4)a
 Non-primary
  Any 11 (26) 5 (15)a,b 5 (42)a 23 (85)c–e 17 (77)d,e 8 (33)a,b
  Inc 9 (21) 4 (12)a,b 4 (33) 20 (74)d,e 14 (64)d 7 (29)a
  Dec 2 (5) 3 (9) 3 (25) 7 (26) 7 (32) 2 (8)
 Religion
  Any (Inc) 1 (2) 0 (0) 1 (8) 4 (15) 5 (23) 2 (8)
 Music
  Any 4 (10) 4 (12)a,b 4 (33) 16 (59)d,e 13 (59)d,e 2 (8)a,b
  Inc 3 (7) 2 (6)a,b 1 (8) 12 (44)d,e 11 (50)d,e 1 (4)a,b
  Dec 1 (2) 2 (6) 3 (25) 4 (15) 2 (9) 1 (4)
 Art
  Any 2 (5) 2 (6) 1 (8) 9 (33) 5 (23) 3 (12)
  Inc 1 (2) 1 (3) 1 (8) 4 (15) 0 (0) 1 (4)
  Dec 1 (2) 1 (3) 0 (0) 5 (19) 5 (23) 2 (8)
 Colours
  Any (Inc) 6 (14) 2 (6) 2 (17) 7 (26) 4 (18) 3 (12)
 All 13 (31) 22 (65)a 8 (67) 26 (96)d,e 19 (86) 16 (67)a

The table summarizes general demographic and clinical data, and the prevalence of altered reward behaviours in each of the sampled hedonic domains for each participant group, as determined from the symptom survey (see text and Supplementary Table 2). Counts, mean (standard deviation) or median (interquartile range) are shown for demographic and clinical data. Raw counts and percentage of group exhibiting each symptom are shown for each reward domain. Significant differences (PFDR < 0.05) between patient groups and healthy controls are in bold; significant differences between patient groups are coded as follows: asignificantly different from bvFTD, bsignificantly different from svPPA, csignificantly different from lvPPA, dsignificantly different from AD, esignificantly different from nfvPPA. AD, patient group with typical Alzheimer’s disease; Any, any change in responsiveness toward that reward; bvFTD, patient group with behavioural variant frontotemporal dementia; Change, overall frequency and dominant direction of behavioural alteration (see text); Controls, healthy control group; Dec, primarily decreased responsiveness; f, female; Handed, handedness; Illness, estimated symptom duration; Inc, primarily increased responsiveness; symptom duration; L, left; lvPPA, patient group with logopenic variant primary progressive aphasia; m, male; MMSE, Mini-Mental State Examination (maximum score 30);52 no., number; nfvPPA, patient group with non-fluent/agrammatic variant primary progressive aphasia; R, right; svPPA, patient group with semantic variant primary progressive aphasia; y, years.